Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).

Abstract in brief

• The study found that patients with metabolic syndrome (MetS) showed larger prostate features such as intravesical prostatic protrusion (IPP), total prostate volume (TPV), and transitional zone volume (TZV), suggesting a link between MetS and benign prostatic enlargement (BPE).
• Certain factors like high-density lipoprotein (HDL) cholesterol levels and hypertension were independently associated with prostate measurements, with high HDL being linked to smaller prostate size and hypertension to larger prostate features.
• Overall, the research suggests that metabolic syndrome is connected to changes in prostate morphology, especially increased IPP, which may impact the severity of lower urinary tract symptoms in men with BPE.]